BEUDAMED
    FDA Recall Terminated

    Boston Scientific, Contour SE Microspheres, for tumor treatment. UPN Codes: Description: M001761101 Contour SE/100-300/1mL/2vials M001761122 Contour SE/100-300/1mL/5vials M001761141 Contour SE/100-300/2mL/2vials M001761162 Contour SE/100-300/2mL/5vials M001761201 Contour SE/300-500/1mL/2vials M001761222 Contour SE/300-500/1mL/5vials M001761241 Contour SE/300-500/2mL/2vials M001761262 Contour SE/300-500/2mL/5vials M001761301 Contour SE/500-700/1mL/2vials M001761322 Contour SE/500-700/1mL/5vials M001761341 Contour SE/500-700/2mL/2vials M001761362 Contour SE/500-700/2mL/5vials M001761401 Contour SE/700-900/1mL/2vials M001761422 Contour SE/700-900/1mL/5vials M001761441 Contour SE/700-900/2mL/2vials M001761462 Contour SE/700-900/2mL/5vials M001761501 Contour SE/900-1200/1mL/2vials M001761522 Contour SE/900-1200/1mL/5vials M001761541 Contour SE/900-1200/2mL/2vials M001761562 Contour SE/900-1200/2mL/5vials

    Recall: Z-2109-2009 · Initiated August 17, 2009

    Recall

    Recall Number
    Z-2109-2009
    Event Number
    53179
    Firm
    Boston Scientific Corporation
    FEI Number
    3002095335
    Product Code
    NAJ
    Status
    Terminated
    Root Cause
    Process design
    Initiated
    August 17, 2009
    Posted
    September 15, 2009
    Terminated
    December 18, 2011
    Address
    1 Scimed Pl, Maple Grove, MN, 55311-1565

    Description

    Boston Scientific, Contour SE Microspheres, for tumor treatment. UPN Codes: Description: M001761101 Contour SE/100-300/1mL/2vials M001761122 Contour SE/100-300/1mL/5vials M001761141 Contour SE/100-300/2mL/2vials M001761162 Contour SE/100-300/2mL/5vials M001761201 Contour SE/300-500/1mL/2vials M001761222 Contour SE/300-500/1mL/5vials M001761241 Contour SE/300-500/2mL/2vials M001761262 Contour SE/300-500/2mL/5vials M001761301 Contour SE/500-700/1mL/2vials M001761322 Contour SE/500-700/1mL/5vials M001761341 Contour SE/500-700/2mL/2vials M001761362 Contour SE/500-700/2mL/5vials M001761401 Contour SE/700-900/1mL/2vials M001761422 Contour SE/700-900/1mL/5vials M001761441 Contour SE/700-900/2mL/2vials M001761462 Contour SE/700-900/2mL/5vials M001761501 Contour SE/900-1200/1mL/2vials M001761522 Contour SE/900-1200/1mL/5vials M001761541 Contour SE/900-1200/2mL/2vials M001761562 Contour SE/900-1200/2mL/5vials

    Reason

    Compromised sterility: Boston Scientific is initiating a Recall Removal for twenty (20) UPN codes and 638 associated lots/batches of its Contour SE Microspheres product. All affected product is packaged within a vial. Boston Scientific has determined that, for affected products, the sterile barrier in the packaging (pouch) that contains the vial may be breached. The breach of sterility could l

    Action

    Boston Scientific sent consignees an "Urgent Medical Device Recall Removal" letter dated August 28, 2009. The letter was addressed to Risk Manger / Field Action Contact. The letter described the problem and the product and advised the consignee to cease immediately the distribution and use of the product. Requested consignees to return affected product to Boston Scientific. The letter enclosed the Recall Instructions, Reply Verification Tracking Form and Field Action Return Shipping Label.

    Distribution

    Worldwide distribution: USA, United Arab Emir., Argentina, Austria, Australia, Belgium, Brazil, Canada, Switzerland, China, Colombia, Costa Rica, Czech Republic, Germany, Denmark, Algeria, Ecuador, Egypt, Spain, Finland, France, Great Britain, Greece, Hong Kong, Hungary, Ireland, Israel, Italy, Jordan, South Korea, Kuwait, Lebanon, Latvia, Libya, Mexico, Namibia, Nicaragua, Netherlands, Norway, New Zealand, Oman, Panama, Poland, Puerto Rico, Portugal, Russian Fed., Saudi Arabia, Sweden, Slovakia, Tunisia, Turkey, Taiwan, Ukraine, and South Africa.

    Quantity

    45,724 (13,048 US, 45,724 OUS)